Navigation Links
UTSA wins San Antonio Area Foundation grant to further chlamydia research
Date:6/23/2009

San Antonio Ashlesh Murthy, the newest research assistant professor in the South Texas Center for Emerging Infectious Diseases (STCEID) at The University of Texas at San Antonio (UTSA), has received a $32,000 grant from the Semp Russ Foundation of the San Antonio Area Foundation to study the role of CD8-positive T-cells in chlamydia infections. Chlamydia, caused by the bacterium Chlamydia trachomatis, is the nation's most common bacterial sexually transmitted disease.

Nearly 2.8 million new chlamydia cases are reported each year in the United States, according to the Centers for Disease Control and Prevention; the disease is most prevalent among teen girls. The infection rate in Texas is slightly higher than the national average. Nearly 17% of Texas females in the 15-19 age group test positive for the infection.

However, experts believe even more chlamydia cases exist than are reported, because the disease generally progresses without exhibiting noticeable symptoms. Left untreated, chlamydia infections can do severe damage in women, causing ectopic pregnancies, pelvic inflammatory disease and even infertility. In men, complications can occur but are generally less severe.

Murthy, a practicing physician from India, entered the Ph.D. program in cellular and molecular biology (CMB) at UTSA in 2002. Working alongside Bernard Arulanandam, professor of microbiology and immunology in UTSA's Department of Biology, Murthy has conducted significant chlamydia research, resulting in findings that have been presented both nationally and internationally by UTSA's chlamydia team.

In 2006, Murthy earned his Ph.D., the first CMB Ph.D. degree awarded by the university. Thereafter, he completed two years of post-doctoral research in UTSA's infectious disease center. Recently, he joined UTSA's Department of Biology as a research assistant professor. The San Antonio Area Foundation award is Murthy's first funding as principal investigator.

"We know that CD8-positive T-cells respond to chlamydia infection, but it is not clear how they affect the infection process and disease development," said Murthy, the study's principal investigator. "The grant from the San Antonio Area Foundation will help us explore the role of these cells and obtain better insights."


'/>"/>

Contact: Christi Fish
christi.fish@utsa.edu
210-458-7584
University of Texas at San Antonio
Source:Eurekalert

Related biology news :

1. Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25
2. CTRC-AACR San Antonio Breast Cancer Symposium
3. 31st Annual San Antonio Breast Cancer Symposium
4. The BBVA Foundation presents its Frontiers of Knowledge Awards
5. Five outstanding young gastroenterologists receive AGA Foundation 2009 Research Scholars Award
6. Society of Interventional Radiology Foundation awards $191,000 in grants
7. The evolutionary foundation of genomic imprinting in lower vertebrates
8. UC Davis bioengineer receives Hartwell Foundation grant to address skull fusion disorder of infants
9. G. Unger Vetlesen Foundation funds purchase of state-of-the-art equipment for UMs Rosenstiel School
10. $10 million Simons Foundation gift supports new initiative with Institute for Advanced Study
11. Innerscope Research(R) Receives Three Great Minds Innovation Awards from the Advertising Research Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology: